2025 Journal Article An mRNA vaccine encoding five conserved Group A Streptococcus antigensHarbison-Price, Nichaela, Sebina, Ismail, Bolton, Rhiannon A., Finn, Meredith, Cork, Amanda J., Courtney, Isabel G., Hancock, Steven, Pelingon, Ruby, Richter, Johanna, Ericsson, Olivia, Green, Shannon, Cuellar, Celeste, Davis, Laura, Pullinger, Brody, Na, Jack, Elangovan, Gayathiri, De Oliveira, David M. P., Curren, Bodie F., Bickham, Nia, Aguirre, Miguel, Dold, Christina, Brouwer, Stephan, Plante, Obadiah, Belz, Gabrielle T. and Walker, Mark J. (2025). An mRNA vaccine encoding five conserved Group A Streptococcus antigens. Nature Communications, 16 (1) 5439, 1-14. doi: 10.1038/s41467-025-60580-0 |
2025 Journal Article Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineageRichter, Johanna, Cork, Amanda J., Ong, Yvette, Keller, Nadia, Hayes, Andrew J., Schembri, Mark A., Jennison, Amy V., Davies, Mark R., Schroder, Kate, Walker, Mark J. and Brouwer, Stephan (2025). Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage. mBio, 16 (2) e0336624, e0336624. doi: 10.1128/mbio.03366-24 |
2024 Journal Article Efficacy of alum-adjuvanted peptide and carbohydrate conjugate vaccine candidates against Group A Streptococcus pharyngeal infection in a non-human primate modelRivera-Hernandez, Tania, Carnathan, Diane G., Richter, Johanna, Marchant, Patrick, Cork, Amanda J., Elangovan, Gayathiri, Henningham, Anna, Cole, Jason N., Choudhury, Biswa, Moyle, Peter M., Toth, Istvan, Batzloff, Michael R., Good, Michael F., Agarwal, Paresh, Kapoor, Neeraj, Nizet, Victor, Silvestri, Guido and Walker, Mark J. (2024). Efficacy of alum-adjuvanted peptide and carbohydrate conjugate vaccine candidates against Group A Streptococcus pharyngeal infection in a non-human primate model. Vaccines, 12 (4) 382, 1-10. doi: 10.3390/vaccines12040382 |
2021 Journal Article Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infectionRichter, Johanna, Monteleone, Mercedes M, Cork, Amanda J., Barnett, Timothy C., Nizet, Victor, Brouwer, Stephan, Schroder, Kate and Walker, Mark J. (2021). Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection. Immunology and Cell Biology, 99 (10), 1-13. doi: 10.1111/imcb.12499 |
2021 Journal Article Inflammasome activation and IL ‐1β signalling in Group A Streptococcus diseaseRichter, Johanna, Brouwer, Stephan, Schroder, Kate and Walker, Mark J. (2021). Inflammasome activation and IL ‐1β signalling in Group A Streptococcus disease. Cellular Microbiology, 23 (9) e13373, 1-9. doi: 10.1111/cmi.13373 |
2020 Journal Article Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenesBrouwer, Stephan, Barnett, Timothy C., Ly, Diane, Kasper, Katherine J., De Oliveira, David M. P., Rivera-Hernandez, Tania, Cork, Amanda J., McIntyre, Liam, Jespersen, Magnus G., Richter, Johanna, Schulz, Benjamin L., Dougan, Gordon, Nizet, Victor, Yuen, Kwok-Yung, You, Yuanhai, McCormick, John K., Sanderson-Smith, Martina L., Davies, Mark R. and Walker, Mark J. (2020). Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes. Nature Communications, 11 (1) 5018, 5018. doi: 10.1038/s41467-020-18700-5 |
2020 Journal Article Preclinical evaluation of a novel SHIP1 phosphatase activator for inhibition of PI3K signaling in malignant B cellsLemm, Elizabeth A., Valle-Argos, Beatriz, Smith, Lindsay D., Richter, Johanna, Gebreselassie, Yohannes, Carter, Matthew J., Karolova, Jana, Svaton, Michael, Helman, Karel, Weston-Bell, Nicola J., Karydis, Laura, Williamson, Chris T., Lenz, Georg, Pettigrew, Jeremy, Harwig, Curtis, Stevenson, Freda K., Cragg, Mark, Forconi, Francesco, Steele, Andrew J., Cross, Jennifer, Mackenzie, Lloyd, Klener, Pavel and Packham, Graham (2020). Preclinical evaluation of a novel SHIP1 phosphatase activator for inhibition of PI3K signaling in malignant B cells. Clinical Cancer Research, 26 (7), 1700-1711. doi: 10.1158/1078-0432.ccr-19-2202 |
2020 Journal Article Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodiesRivera-Hernandez, Tania, Rhyme, Mira Syahira, Cork, Amanda J., Jones, Scott, Segui-Perez, Celia, Brunner, Livia, Richter, Johanna, Petrovsky, Nikolai, Lawrenz, Maria, Goldblatt, David, Collin, Nicolas and Walker, Mark J. (2020). Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodies. mBio, 11 (2) e00122-20. doi: 10.1128/mbio.00122-20 |
2019 Journal Article Detection of epidemic scarlet fever group A Streptococcus in AustraliaWalker, Mark J., Brouwer, Stephan, Forde, Brian M., Worthing, Kate A., McIntyre, Liam, Sundac, Lana, Maloney, Sam, Roberts, Leah W., Barnett, Timothy C., Richter, Johanna, Cork, Amanda J., Irwin, Adam D., You, Yuanhai, Zhang, Jianzhong, Dougan, Gordon, Yuen, K. Y., Nizet, Victor, Beatson, Scott A., Grimwood, Keith and Davies, Mark R. (2019). Detection of epidemic scarlet fever group A Streptococcus in Australia. Clinical Infectious Diseases, 69 (7), 1232-1234. doi: 10.1093/cid/ciz099 |